Overview
GUTS market data
Price History
GUTS price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$1.86 Diluted earnings per share over the trailing twelve months.
- Beta
- 2.33 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -73,864.5% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $0.38 – $2.45 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $107.1M · P/B 31.88 · P/S 1,151.48.
Company News
Fractyl Health Q2 EPS $(0.16) Misses $(0.13) EstimateBenzinga · Aug 10, 2026, 8:07 PM
Fractyl Health Helps Maintain Weight After Stopping Popular Obesity Drugs, Stock SoarsBenzinga · Jul 15, 2026, 6:22 PM
Fractyl Health shares are trading higher after the company announced randomized data from REMAIN-1 Midpoint Cohort demonstrating durable weight maintenance one year after GLP-1 discontinuation.Benzinga · Jul 15, 2026, 6:21 PM
Fractyl Health Announces One-Year Results From Its REMAIN-1 Midpoint Cohort; Results Reinforce Potential Of Revita DMR System To Become First Durable Therapy For Post-GLP-1 Weight MaintenanceBenzinga · Jul 15, 2026, 10:02 AM
8-K filing — FRACTYL HEALTH, INC. (GUTS)SEC EDGAR · Jul 15, 2026, 10:00 AM
HC Wainwright & Co. Reiterates Buy on Fractyl Health, Maintains $8 Price TargetBenzinga · Jun 4, 2026, 4:55 PM
Fractyl Health Announces 1-Yr Results From Open-Label REVEAL-1 Cohort; Participants Retained ~78% Of GLP-1 Induced Total Body Weight Loss One Year After Discontinuation And Single Revita ProcedureBenzinga · Jun 4, 2026, 11:10 AM